Boston Bioscience Inc.
- UEI
- R6ZST876WNU9
- CAGE
- 3YHT3
- SAM.gov registration
- Expired
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| For covid-19 boston biosciences protein ebov and cars-COV2 synthesis | National Institute of Allergy and Infectious Diseases | $248,888 | |
| 20-001353 / moog medical | National Heart Lung and Blood Institute | $11,166 | |
| Ebola peptides 9 residues QTY of 60 @ $300.00 | National Institute of Allergy and Infectious Diseases | $18,050 | |
| Ebola peptides 7 residues | National Institute of Allergy and Infectious Diseases | $13,150 | |
| Ambis# 1642842 - ebola GP (s/b) carboxyl terminus acid peptides, 15 amino acids in length, 5MG, (QTY 88 @ $288.00/each) | NIAID DEA OA Acquisitions | $25,633 |
Quick answers
What is Boston Bioscience Inc.'s UEI?
Boston Bioscience Inc.'s Unique Entity ID (UEI) in SAM.gov is R6ZST876WNU9.
What is Boston Bioscience Inc.'s CAGE code?
Boston Bioscience Inc.'s CAGE code is 3YHT3.
What is Boston Bioscience Inc.'s primary NAICS code?
Boston Bioscience Inc.'s primary NAICS code is 541990 (All Other Professional, Scientific, and Technical Services).
Is Boston Bioscience Inc. registered in SAM.gov?
Boston Bioscience Inc.'s SAM.gov registration expired on February 16, 2022.
What is Boston Bioscience Inc.'s most recent federal award?
Boston Bioscience Inc.'s most recent federal contract award is For covid-19 boston biosciences protein ebov and cars-COV2 synthesis (75N93020P01156), from National Institute of Allergy and Infectious Diseases, on August 26, 2020.
On GovTribe
See Boston Bioscience Inc.'s full federal record
- Federal contract awards
- IDV awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors